Rheos is a precision medicine company using insights from immunometabolism to bring novel therapeutics to patients suffering from autoimmune diseases. Our proprietary platform elucidates the complexities and heterogeneity of immune-mediated disease by investigating multi-omic datasets through a metabolic lens. This insight drives a deep pipeline of biomarker-enabled small molecule precision therapies.
Deep Precision Pipeline
Continuous and efficient advancement of small molecule therapeutics
Target engagement and pharmacodynamics enhance success
Matching the right drugs to the right patients
Application of core capabilities into new areas of biology to enable expansion & partnering
Our platform gives us insights into the specific drivers of patients’ disease – advancing the delivery of the right treatment to the right patient at the right time.